A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2014-05-30
Summary
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
-
KCT-0809
- DRUG
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
More Related Trials
-
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
NCT00721656 ·Status: COMPLETED ·Phase: PHASE2
-
An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503176 ·Status: TERMINATED ·Phase: PHASE3
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
NCT02092207 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye
NCT00799552 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RX-10045 in the Treatment of Dry Eye Disease
NCT01675570 ·Status: COMPLETED ·Phase: PHASE2
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers
NCT04104997 ·Status: COMPLETED ·Phase: PHASE1
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Study of ST-100 as Treatment for Dry Eye Disease
NCT05241470 ·Status: COMPLETED ·Phase: PHASE2
-
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1